Nov 01,2017

Insulet Corporation Raises Awareness for Diabetes Community During National Diabetes Awareness Month

Insulet Corporation (NASDAQ: PODD) (Insulet or the Company) the leader in tubeless insulin pump technology with its Omnipod® Insulin Management System (Omnipod System), is recognizing National Diabetes Awareness Month with various initiatives to highlight Insulet's commitment to raising awareness of diabetes.

View Analyst & Ambassador Comments
Go to original news
Nov 02,2017

Nemaura Medical Inc. Reports Second Quarter 2017 Financial Results

Nemaura Medical Inc. (OTCQB: NMRD), a medical technology company developing sugarBEAT® as a non-invasive, affordable and flexible glucose monitoring system for adjunctive use by persons with diabetes, recently reported financial results for the second quarter ended September 30, 2017. Research and development expenses were $209,087 and $220,714 for the three months ended September 30, 2017 and 2016, respectively.

View Analyst & Ambassador Comments
Go to original news
Nov 02,2017

Human Factors Research Presented at DTM 2017 Demonstrates Ease of Use and Effectiveness of Computer-Based Training for Touchscreen Insulin Pump with Automated Insulin Delivery Feature

Tandem Diabetes Care®, Inc. (NASDAQ: TNDM), a medical device company and manufacturer of the only touchscreen insulin pumps available in the United States, today presented results from a Human Factors study conducted to validate the safety of the user interface of a predictive low glucose suspend (PLGS) feature as part of the t:slim X2™ Insulin Pump. The study included users ages 6 and up (N=53), with and without experience using an insulin pump or continuous glucose monitoring (CGM).

CLINICAL STUDY

#insulin pump

View Analyst & Ambassador Comments
Go to original news
Nov 02,2017

BD Announces Results for 2017 Fourth Fiscal Quarter and Full Year

BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today reported quarterly revenues of $3.166 billion for the fourth fiscal quarter ended September 30, 2017. The Company's Diabetes Care revenue reached to $136 million in the Q4 of 2017, increased by 4% YoY.

View Analyst & Ambassador Comments
Go to original news
Nov 02,2017

Insulet Reports Third Quarter 2017 Financial Results

Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the leader in tubeless insulin pump technology with its Omnipod® Insulin Management System (Omnipod System), today announced financial results for the three months ended September 30, 2017. The Company's third quarter 2017 revenue increased 28% to $121.8 million, compared to revenue of $94.9 million in the third quarter of 2016.

View Analyst & Ambassador Comments
Go to original news
Nov 06,2017

One Drop Announces Regulatory Approval And Launch In Canada

One Drop today announced Health Canada approval for One Drop | Chrome, its Bluetooth-enabled blood glucose monitoring system that syncs directly with the One Drop | Mobile app.

PRODUCT

#mobile app

#bgm

View Analyst & Ambassador Comments
Go to original news
Nov 06,2017

DarioHealth to Host Third Quarter Conference Call on November 14, 2017

DarioHealth Corp. (NASDAQ: DRIO), a leading global digital health company with mobile health and big data solutions, today announced that it will release its third quarter 2017 results on Tuesday, November 14 and host a conference call at 9:00am ET.

View Analyst & Ambassador Comments
Go to original news
Nov 06,2017

Brighter recruits CFO for upcoming growth phase and investor relations.

Ann Zetterberg will act as new CFO in Brighter and will also be part of the company's management team. Zetterberg has over 20 years of experience as CFO from numerous different operations.

View Analyst & Ambassador Comments
Go to original news
Nov 06,2017

Insulet Announces Private Offering of Convertible Senior Notes

Insulet Corporation (NASDAQ:PODD) (Insulet or the Company), a leader in tubeless insulin pump technology with its Omnipod® Insulin Management System (Omnipod System), today announced its intention to offer, subject to market and other conditions, $300 million principal amount of convertible senior notes due 2024 (the Notes) in a private placement.

View Analyst & Ambassador Comments
Go to original news
Nov 07,2017

Tandem Diabetes Care to Present at the Stifel 2017 Healthcare Conference

Tandem Diabetes Care®, Inc. (NASDAQ: TNDM), a medical device company and manufacturer of the only touchscreen insulin pumps available in the United States, today announced that Kim Blickenstaff, president and CEO, will present a company update at the Stifel 2017 Healthcare Conference in New York, NY. The presentation will take place on Tuesday, November 14, 2017 at 2:00PM Eastern Time (11:00AM Pacific Time).

CONFERENCES
View Analyst & Ambassador Comments
Go to original news
Subscribe to DIABETES